BioMarin Pharmaceutical Inc. ‘s ( BMRN ) third quarter 2012 loss of 4 cents per share was narrower than the Zacks Consensus loss estimate of 21 cents per share and the year-ago loss of
Excerpt from:
BioMarin Reports Narrower Loss – Analyst Blog
BioMarin Pharmaceutical Inc. ‘s ( BMRN ) third quarter 2012 loss of 4 cents per share was narrower than the Zacks Consensus loss estimate of 21 cents per share and the year-ago loss of
Excerpt from:
BioMarin Reports Narrower Loss – Analyst Blog